艾司氯胺酮联合瑞马唑仑在肥胖患者宫腔镜手术的应用
The Application of Esketamine Combined with Remimazolam in Hysteroscopic Surgery of Obese Patients
DOI: 10.12677/acm.2025.151272, PDF,   
作者: 栾英俊, 张成明*:山东第二医科大学麻醉学院,山东 潍坊;吕渐峰:平度市人民医院重症医学科,山东 平度;杨永辉:寿光市中医医院麻醉科,山东 寿光
关键词: 艾司氯胺酮瑞马唑仑宫腔镜肥胖Esketamine Remimazolam Hysteroscopy Obese
摘要: 目的:通过比较艾司氯胺酮联合瑞马唑仑与舒芬太尼联合丙泊酚在肥胖患者宫腔镜手术中的麻醉效果,评估肥胖患者使用艾司氯胺酮联合瑞马唑仑的安全性及可行性。方法:选取拟行宫腔镜手术的76例肥胖患者为研究对象,将其完全随机分为实验组(A组)和对照组(C组)。A组采用艾司氯胺酮联合瑞马唑仑复合麻醉,C组采用舒芬太尼联合丙泊酚复合麻醉,比较两组的麻醉效果和安全性。观察并记录各组患者入室时(T1)、麻醉诱导后3 min (T2)、扩张宫颈(T3)及苏醒时(T4)四个时间段的呼吸(PetCO2, SpO2, RR)及循环(MAP、HR)的变化情况;记录麻醉相关不良事件的发生率、患者的满意度及麻醉药物输注后的起效时间、检查时间和苏醒时间,并进行比较。结果:两组患者的年龄、身高、体重、BMI等基本资料相比较无统计学差异(P > 0.05);与C组相比,A组患者的PetCO2、SPO2、平均动脉压、心率及呼吸频率的波动均小于对照组,差异有统计学意义(P < 0.05);A组患者麻醉诱导时间、苏醒时间均短于C组,差异有统计学意义(P < 0.05);两组患者术中检查时间差异无统计学意义(P > 0.05);A组患者不良反应发生率低于C组,差异有统计学意义(P < 0.05),A组患者总满意度高于C组,差异有统计学意义(P < 0.05)。
Abstract: Objective: By comparing the anesthetic effects of the combination of esketamine and remimazolam with those of sufentanil and propofol in obese patients undergoing hysteroscopy, we assessed the safety and feasibility of using esketamine and remimazolam in this patient population. Methods: 76 obese patients undergoing hysteroscopic surgery were selected as the research object and randomly divided into an experimental group (group A) and a control group (group C). Group A was given combined anesthesia with esketamine and remimazolam, while Group C was given combined anesthesia with sufentanil and propofol. The anesthetic effects and safety of the two groups were compared. The respiratory (PetCO2, SpO2, RR) and circulatory (MAP, HR) parameters were observed and recorded at four-time points: upon entering the operating room (T1), 3 minutes after anesthesia induction (T2), during cervical dilation (T3), and at the time of emergence from anesthesia (T4). The incidence of anesthesia-related adverse events, patient satisfaction, and the onset time of anesthesia drugs, procedure duration, and emergence time were also recorded and compared among the groups. Results: There was no statistical difference in age, height, weight and BMI between the two groups (P > 0.05). Compared with group C, the fluctuation of PetCO2, SPO2, mean arterial pressure, heart rate and respiratory rate in group A was less than that in the control group, and the difference was statistically significant (P < 0.05). The induction time and recovery time of anesthesia in group A were shorter than those in group C, and the difference was statistically significant (P < 0.05). There was no significant difference in the time of intraoperative examination between the two groups (P > 0.05). The incidence of adverse reactions in group A was lower than that in group C (P < 0.05), and the total satisfaction of patients in group A was higher than that in group C (P < 0.05).
文章引用:栾英俊, 张成明, 吕渐峰, 杨永辉. 艾司氯胺酮联合瑞马唑仑在肥胖患者宫腔镜手术的应用[J]. 临床医学进展, 2025, 15(1): 2049-2058. https://doi.org/10.12677/acm.2025.151272

参考文献

[1] 都淑萍, 王晓东, 潘红霞, 等. 右美托咪定、丙泊酚联合小剂量艾司氯胺酮在宫腔镜手术中的临床应用[J]. 国际医药卫生导报, 2022, 28(15): 2093-2097.
[2] Li, S., Wu, B., Peng, B., et al. (2022) The Choice of Anesthetic Drugs in Outpatient Hysteroscopic Surgery: A Systematic Review and Network Meta-Analysis. Disease Markers, 2022, Article ID: 2408685.
[3] Kumar, S. and Kelly, A.S. (2017) Review of Childhood Obesity: From Epidemiology, Etiology, and Comorbidities to Clinical Assessment and Treatment. Mayo Clinic Proceedings, 92, 251-265. [Google Scholar] [CrossRef] [PubMed]
[4] Eberl, S., Koers, L., van Hooft, J.E., de Jong, E., Schneider, T., Hollmann, M.W., et al. (2017) Sedation with Propofol during ERCP: Is the Combination with Esketamine More Effective and Safer than with Alfentanil? Study Protocol for a Randomized Controlled Trial. Trials, 18, Article No. 472. [Google Scholar] [CrossRef] [PubMed]
[5] 米军桥, 江岩, 王世端, 等. 右美托咪定-氯胺酮静脉复合麻醉在宫颈锥切术中的临床应用[J]. 中国新药与临床杂志, 2019, 38(1): 33-37.
[6] 钱夏丽, 夏凡, 沈晓凤, 等. 艾司氯胺酮复合丙泊酚在宫腔镜检查术中的应用[J]. 临床麻醉学杂志, 2021, 37(7): 706-708.
[7] 肖兴鹏, 郭明, 马岚, 等. 瑞马唑仑-丙泊酚-舒芬太尼用于无痛胃镜检查术患者麻醉的效果[J]. 中华麻醉学杂志, 2021, 41(2): 192-194.
[8] 王春艳, 泳浩. 瑞马唑仑临床研究进展[J]. 中华麻醉学杂志, 2019, 39(3): 261-263.
[9] Wang, L., Zhou, B., Zhao, Z., Yang, L., Zhang, M., Jiang, Y., et al. (2021) Body-Mass Index and Obesity in Urban and Rural China: Findings from Consecutive Nationally Representative Surveys during 2004-18. The Lancet, 398, 53-63. [Google Scholar] [CrossRef] [PubMed]
[10] 王哲, 王海燕, 吕志敢, 等. 艾司氯胺酮与舒芬太尼联合丙泊酚用于宫腔镜手术麻醉效果比较[J]. 中国药业, 2023, 32(1): 91-93.
[11] 唐庆, 杨宁, 王刚, 等. 肥胖与OSAHS关系及治疗的研究进展[J]. 临床肺科杂志, 2016, 21(1): 125-129.
[12] 杨丽娟, 黎颖红, 梁宇鹏, 等. 不同血浆靶浓度阿芬太尼复合瑞马唑仑用于宫腔镜手术麻醉效果的比较[J]. 中华麻醉学杂志, 2023, 43(6): 746-748.
[13] Goudra, B., Gouda, G. and Mohinder, P. (2020) Recent Developments in Drugs for GI Endoscopy Sedation. Digestive Diseases and Sciences, 65, 2781-2788. [Google Scholar] [CrossRef] [PubMed]
[14] Li, M., Ke, W. and Zhuang, S. (2022) Effect of Intravenous Lidocaine on Propofol Consumption in Elderly Patients Undergoing Colonoscopy: A Double-Blinded, Randomized, Controlled Trial. BMC Anesthesiology, 22, Article No. 61. [Google Scholar] [CrossRef] [PubMed]
[15] Baker, M.T., Naguib, M. and Warltier, D.C. (2005) Propofol. Anesthesiology, 103, 860-876. [Google Scholar] [CrossRef] [PubMed]
[16] 孙丽华, 郑海波, 范莹莹, 潘振祥. 地氟烷与丙泊酚用于肥胖病人妇科腹腔镜手术后苏醒质量的比较[J]. 中国实验诊断学, 2018, 22(6): 1013-1014.
[17] De Cosmo, G., Levantesi, L. and Del Vicario, M. (2020) Sedation in Digestive Endoscopy: Innovations for an Old Technique. Minerva Anestesiologica, 86, 565-570. [Google Scholar] [CrossRef] [PubMed]
[18] Lohmer, L.L., Schippers, F., Petersen, K.U., Stoehr, T. and Schmith, V.D. (2020) Time‐to‐Event Modeling for Remimazolam for the Indication of Induction and Maintenance of General Anesthesia. The Journal of Clinical Pharmacology, 60, 505-514. [Google Scholar] [CrossRef] [PubMed]
[19] 罗凯, 符黄德, 姚洁民. 瑞马唑仑临床应用的研究进展[J]. 中华重症医学电子杂志, 2021, 7(1): 71-75.
[20] Pambianco, D., Borkett, K., Riff, D., et al. (2016) A Phase IIb Study Comparing the Safety and Efficacy of Remimazolam and Midazolam in Patients Undergoing Colonoscopy. Gastrointestinal Endoscopy, 83, 984-992.
[21] 马漪洁, 张玉, 陈占军, 鲍乐乐. 苯磺酸瑞马唑仑用于病态肥胖患者无痛胃镜检查的效果[J]. 河南外科学杂志, 2022, 28(3): 60-62.
[22] Jonkman, K., van Rijnsoever, E., Olofsen, E., Aarts, L., Sarton, E., van Velzen, M., et al. (2018) Esketamine Counters Opioid-Induced Respiratory Depression. British Journal of Anaesthesia, 120, 1117-1127. [Google Scholar] [CrossRef] [PubMed]
[23] Motov, S., Drapkin, J., Likourezos, A., Doros, J., Monfort, R. and Marshall, J. (2018) Sub-Dissociative Dose Ketamine Administration for Managing Pain in the Emergency Department. World Journal of Emergency Medicine, 9, 249-225. [Google Scholar] [CrossRef] [PubMed]
[24] Dargin, J. and Medzon, R. (2010) Emergency Department Management of the Airway in Obese Adults. Annals of Emergency Medicine, 56, 95-104. [Google Scholar] [CrossRef] [PubMed]
[25] Trimmel, H., Helbok, R., Staudinger, T., Jaksch, W., Messerer, B., Schöchl, H., et al. (2018) S(+)-Ketamine: Current Trends in Emergency and Intensive Care Medicine. Wiener Klinische Wochenschrift, 130, 356-366. [Google Scholar] [CrossRef] [PubMed]
[26] Miziara, L.E.D.P.G., Simoni, R.F., Esteves, L.O., Cangiani, L.H., Grillo-Filho, G.F.R. and Paula, A.G.L.E. (2016) Efficacy of Continuous S(+)-Ketamine Infusion for Postoperative Pain Control: A Randomized Placebo-Controlled Trial. Anesthesiology Research and Practice, 2016, Article ID: 6918327. [Google Scholar] [CrossRef] [PubMed]